Gastrointestinal symptoms as an important sign in premature newborns with severely increased S-digoxin

Mads Nybo1, Per Damkier

  • 1Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, DK-5000 Odense, Denmark. mads.nybo@ouh.fyns-amt.dk

Insights

Digoxin intoxication in newborns often presents with extracardiac symptoms, not cardiac ones. Alertness to gastrointestinal signs and monitoring potassium levels are crucial for early detection in infants.

Area of Science:

  • Neonatal pharmacology
  • Pediatric toxicology

Background:

  • Digoxin is commonly prescribed for neonatal heart conditions.
  • Adults typically exhibit cardiac symptoms during digoxin intoxication.
  • Infants, especially preterm neonates, display altered digoxin sensitivity and tissue distribution.

Observation:

  • A case of severe digoxin intoxication in a preterm infant is presented.
  • The infant exhibited significant gastrointestinal symptoms with minimal cardiac effects.
  • Altered symptomatology in neonates can delay diagnosis of digoxin overdose.

Findings:

  • Extracardiac symptoms, particularly gastrointestinal, are critical indicators of digoxin intoxication in newborns.
  • Elevated serum potassium (P-Potassium) can predict digoxin toxicity.
  • Therapeutic drug monitoring is essential when digoxin overdose is suspected in neonates.

Implications:

  • Increased clinical awareness of non-cardiac digoxin toxicity signs in neonates is vital.
  • Early detection through monitoring extracardiac symptoms and potassium levels can prevent severe outcomes.
  • Standardized therapeutic drug monitoring protocols are needed for neonatal digoxin use.